Growth Metrics

Lisata Therapeutics (LSTA) Deferred Taxes (2016 - 2017)

Lisata Therapeutics filings provide 8 years of Deferred Taxes readings, the most recent being -$49531.0 for Q1 2017.

  • For the quarter ending Q1 2017, Deferred Taxes rose 7.21% year-over-year to -$49531.0, compared with a TTM value of $3847.0 through Mar 2017, down 99.98%, and an annual FY2017 reading of $11.5 million, changed N/A over the prior year.
  • Deferred Taxes hit -$49531.0 in Q1 2017 for Lisata Therapeutics, down from $147286.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $13.6 million in Q4 2015, with the low at -$447568.0 in Q2 2013.
  • Median Deferred Taxes over the past 5 years was -$46793.5 (2015), compared with a mean of $1.1 million.
  • The sharpest move saw Deferred Taxes plummeted 263.95% in 2013, then skyrocketed 7915.15% in 2015.
  • Year by year, Deferred Taxes stood at -$287779.0 in 2013, then soared by 185.62% to $246385.0 in 2014, then skyrocketed by 5433.39% to $13.6 million in 2015, then tumbled by 98.92% to $147286.0 in 2016, then crashed by 133.63% to -$49531.0 in 2017.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$49531.0, $147286.0, and -$46954.0 for Q1 2017, Q4 2016, and Q3 2016 respectively.